PI3-Kinase Upregulation and Involvement in Spontaneous Tone in Arteries from DOCA-Salt Rats: Is p110δ the Culprit?

Hypertension

Volumn 43, Issue 4, 2004, Pages 885-890

  Northcott, Carrie A ^a   Hayflick, Joel S ^b   Watts, Stephanie W ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Arteries; Hypertension, mineralocorticoid

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ALPHA ACTIN; DEOXYCORTICOSTERONE ACETATE; IC 87114; ISOENZYME; MINERALOCORTICOID; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE P110DELTA SUBUNIT; PROTEIN INHIBITOR; PROTEIN P85; PROTEIN P85ALPHA; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERIOLE; ARTERY RESISTANCE; ARTERY TONE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEOXYCORTICOSTERONE SALT RAT; ENZYME ACTIVITY; ENZYME SUBUNIT; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; MESENTERIC ARTERY; MINERALOCORTICOID HYPERTENSION; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENINE; ANIMALS; AORTA; CHROMONES; DESOXYCORTICOSTERONE; DISEASE MODELS, ANIMAL; ENZYME INDUCTION; ENZYME INHIBITORS; HYPERTENSION; MALE; MESENTERIC ARTERIES; MORPHOLINES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTEIN ISOFORMS; PROTEIN SUBUNITS; QUINAZOLINES; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHLORIDE; VASCULAR RESISTANCE;

EID: 1642501560     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000118518.20331.e8     Document Type: Article

References (24)

1. Wymann MP, Pirola L. Structure and function of phosphoinositide 3-kinases. Biochem Biophys Acta. 1998;1436:127-150.
2. Anderson RA, Boronenkov IV, Doughman SD, Kunz J, Loijens JC. Phosphatidylinositol phosphate kinases, a multifaceted family of signaling enzymes. J Biol Chem. 1999;274:9907-9910.
3. Rameh LE, Cantley, LC. The role of phosphoinositide 3-kinase lipid products in cell function. J Biol Chem. 1999;274:8347-8350.
4. Cantrell DA. Phosphoinositide 3-kinase signaling pathways. J Cell Sci. 2001;114:1439-1445.
5. Coelho CM, Leevers SJ. Do growth and cell division rates determine cell size in multicellular organisms? J Cell Sci. 2000;113:2927-2934.
6. Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Driscoll PC, Woscholski R, Parker PJ, Waterfield MD. Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem. 2001;70:535-602.
7. Northcott CA, Poy MN, Najjar SM, Watts SW. Phosphoinositide 3-kinase mediates enhanced spontaneous and agonist-induced contraction in aorta of deoxycorticosterone acetate-salt hypertensive rats. Circ Res. 2002;91:360-369.
8. Yang ZW, Wang J, Zheng T, Altura BT, Altura BM. Importance of PKC and PI3Ks in ethanol-induced contraction of cerebral arterial smooth muscle. Am J Physiol Heart Circ Physiol. 2001;280:H2144-H2152.
9. Komalavilas P, Mehta S, Wingard CJ, Dransfield DT, Bhalla J, Woodrum JE, Molinaro JR, Brophy CM. PI3-kinase/Akt modulates vascular smooth muscle tone via cAMP signaling pathways. J Appl Physiol. 2001;91:1819-1827.
10. Hollenberg NK, Sandor T. Vasomotion of renal blood flow in essential hypertension. Oscillations in xenon transit. Hypertension. 1984;6:579-585.
11. Hollenberg NK. Vasodilators, antihypertensive therapy and the kidney. Am J Cardiol. 1987;60:57I-60I.
12. Nilsson H, Aalkjaer C. Vasomotion: mechanisms and physiological importance. Mol Int. 2003;3:79-89.
13. Florian JA, Watts SW. Epidermal growth factor: a potent vasoconstrictor in experimental hypertension. Am J Physiol. 1999;276:H976-H983.
14. Kido Y, Burks DJ, Withers D, Bruning JC, Kahn CR, White MF, Accili D. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J Clin Invest. 2000;105:199-205.
15. Poy MN, Ruch RJ, Fernstrom MA, Okabayashi Y, Najjar SM. Shc and CEACAMI interact to regulated the mitogenic action of insulin. J Biol Chem. 2002;277:1076-1084.
16. Safar ME, London GM, Asmar R, Frohlich ED. Recent advances on large arteries in hypertension. Hypertension. 1998;32:156-161.
17. Salaymeh KJ, Banerjee A. Evaluation of arterial stiffness in children with Williams syndrome: does it play a role in evolving hypertension? Am Heart J. 2001;142:549-555.
18. Sadhu C, Dick, K, Tino, WT, Staunton DE. Selective role of PI3Kδin neutrophil inflammatory responses. Biochem Biophys Res Commun. 2003;308:764-769.
19. Oklkenhaug K, Bilancio A, Farjot G, Priddle H, Sancho S, Peskett E, Pearce W, Meek SE, Salpekar A, Waterfield MD, Smith AJ, Vanhaesebroeck B. Impaired B and T cell antigen receptor signaling in p110δPI3-kinase mutant mice. Science. 2002;297:1031-1034.
20. Foukas LC, Daniele N, Ktori C, Anderson KE, Jensen J, Shepherd PR. Direct effects of caffeine and theophylline on p110δ and other phosphoinositide 3-kinases. Differential effects on lipid kinase and protein kinase activities. J Biol Chem. 2002;277:37124-37130.
21. Vanhaesebroeck B, Welham MJ, Kotani K, Stein R, Warne PH, Zvelebil MJ, Higashi K, Volinia S, Downward J, Waterfield MD. p110δ, a novel phosphoinositide 3-kinase in leukocytes. Proc Natl Acad Sci. 1997;94: 4330-4335.
22. Chantry D, Vojtek A, Kashishian A, Holtzman DA, Wood C, Gray PW, Cooper JA, Hoekstra MF. p110δ, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes. J Biol Chem. 1997;272:19236-19241.
23. Sawyer C, Sturge J, Bennet DC, O'Hare MJ, Allen WE, Bain J, Jones GE, Vanhaesebroeck B. Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110δ. Cancer Res. 2003;63:1667-1675.
24. Wymann, MP. Phosphoinositide 3-kinase signaling-which way to target? Trends Pharmacol Sci. 2003;24:366-370.